Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Genetic findings in a Turkish clinical cohort with hereditary Parkinson's disease.

Ozata Aksoy D, Tunca Y, Sonkaya AR, Torun D, Korucu O.

Neurogenetics · 2026-10-06

DOI: 10.1007/s10048-026-00949-5PMID: 42836888

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinical and biomarker predictors of α-synuclein seeding in cognitive impairment and motor parkinsonism.

Ye BS, VandeVrede L, Jeon S, Lee S, Choi M, Jeon S, Shin NY, Charters B, Plastini M, Kang S, Rim JH, Lim JB.

Parkinsonism Relat Disord · 2026-10-04

DOI: 10.1016/j.parkreldis.2026.108956PMID: 42854385

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The Therapeutic Potential of MicroRNAs Delivered By Mesenchymal Stem Cells in Parkinson's Disease, Alzheimer's Disease, and Stroke: A Systematic Review of Preclinical Studies.

Przywara D, Petniak A, Gil-Kulik P.

Mol Neurobiol · 2026-10-03

DOI: 10.1007/s12035-026-06247-3PMID: 42828605

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences-a scoping review.

Gowda N, Harish S.

Neurogenetics · 2026-10-02

DOI: 10.1007/s10048-026-00946-8PMID: 42825921

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.

Rava A, Di Trapano M, Tse C, Ji L, Bid HK, Trezza V.

Neurosci Biobehav Rev · 2026-10-02

DOI: 10.1016/j.neubiorev.2026.107005PMID: 42826598

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Susceptibility-Weighted Imaging in Patients with Corticobasal Syndrome or Progressive Supranuclear Palsy: Distribution of Iron Deposits Reflects Clinical Symptoms in 4-Repeat Tauopathies.

Migaleddu G, Del Prete E, Donatelli G, Frosini D, Ceravolo R, Cosottini M.

AJNR Am J Neuroradiol · 2026-10-01

DOI: 10.3174/ajnr.a9338PMID: 41951427

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum.

Roascio M, Antelmi E, Baldelli L, Biscarini F, Bonanni E, Brunetti V, Capriglia E, Geromino C, Casoni F, Cirillo F, Della Marca G, Di Laudo F, Ferini-Strambi L, Fernandes M, Figorilli M, Galbiati A, Gigli GL, Guarnieri B, Hoxhaj D, Lanza G, Liguori C, Maestri Tassoni M, Maio S, Malomo G, Marelli S, Mattioli P, Mulas M, Orso B, Pardini M, Plazzi G, Provini F, Pellitteri G, Puligheddu M, Terzaghi M, Pelletier A, Postuma RB, Arnulfo G, Arnaldi D, FARPRESTO consortium.

Brain · 2026-10-01

DOI: 10.1093/brain/awag193PMID: 42213896

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Are There Cognitive and Anxiety Improvements in People With Parkinson's Disease After Xbox Kinect Training Compared With No Intervention? A Non-Randomized Controlled Trial.

Ferreira da Silva EC, de Souza Morais W, Carregaro RL, Garcia PA, Leal JC, Mendes FADS.

Physiother Res Int · 2026-10-01

DOI: 10.1002/pri.70306PMID: 42576230

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study.

Shen H, Sun P, Ge B, Xiao J, Han X.

Clin Biochem · 2026-10-01

DOI: 10.1016/j.clinbiochem.2026.111213PMID: 42822624

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Disentangling amantadine response variability in levodopa related dyskinesias: Role of clinical and genetic factors.

Chaparro-Solano HM, Saadatpour L, Yu JRT, Sonneborn C, Peixoto-Leal T, Piccinin CC, Anis S, Kaur H, Assaedi E, Mata IF, Fernandez HH.

Parkinsonism Relat Disord · 2026-10-01

DOI: 10.1016/j.parkreldis.2026.109000PMID: 42832827

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The FOG-COA Protocol: Validation of Freezing of Gait Clinical Outcomes Assessments in Parkinson's Disease.

Howe EE, Ginis P, Ehgoetz Martens KA, Gilat M, Mancini M, Mckay JL, Nonnekes J, Mammen J, Adams JL, Cella D, Nieuwboer A, Horak F, Lewis SJG, Hausdorff JM.

Eur J Neurosci · 2026-10-01

DOI: 10.1111/ejn.70701PMID: 42888898

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Prediction of cognitive impairment in Parkinson's disease using TabPFN: an integrative analysis of clinical data, longitudinal trajectories, and lipidomics.

Zhou Z, Liu J, Wang L, Lv H, Jiang W, Huang L, Zhang G, Ma R.

Front Aging Neurosci · 2026-09-30

DOI: 10.3389/fnagi.2026.1905374PMID: 42877199

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

7.691 makale bulundu

Genetic findings in a Turkish clinical cohort with hereditary Parkinson's disease.

Clinical and biomarker predictors of α-synuclein seeding in cognitive impairment and motor parkinsonism.

The Therapeutic Potential of MicroRNAs Delivered By Mesenchymal Stem Cells in Parkinson's Disease, Alzheimer's Disease, and Stroke: A Systematic Review of Preclinical Studies.

Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences-a scoping review.

Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.

Susceptibility-Weighted Imaging in Patients with Corticobasal Syndrome or Progressive Supranuclear Palsy: Distribution of Iron Deposits Reflects Clinical Symptoms in 4-Repeat Tauopathies.

Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum.

Are There Cognitive and Anxiety Improvements in People With Parkinson's Disease After Xbox Kinect Training Compared With No Intervention? A Non-Randomized Controlled Trial.

Circulating phosphatidylserine as a plasma biomarker for clinical staging and prognostic prediction in Parkinson's disease: A diagnostic validation study.

Disentangling amantadine response variability in levodopa related dyskinesias: Role of clinical and genetic factors.

The FOG-COA Protocol: Validation of Freezing of Gait Clinical Outcomes Assessments in Parkinson's Disease.

Prediction of cognitive impairment in Parkinson's disease using TabPFN: an integrative analysis of clinical data, longitudinal trajectories, and lipidomics.

Filtreler